MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, Ronald B., Berg, Daniela, Stern, Matthew, Poewe, Werner, Olanow, C. Warren, Oertel, Wolfgang, Obeso, José, Marek, Kenneth +10 more·2015·Movement Disorders
DOI 10.1002/mds.26424

Cited by (1,019)

Items 101–200 of 1,019

  1. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation
    Lorenzo Gaetani, Kina Höglund, Lucilla Parnetti, Fani Pujol-Calderón, Bruno Becker, Paolo Eusebi, Paola Sarchielli, Paolo Calabresi, Massimiliano Di Filippo, Henrik Zetterberg et al. · 2018 · Alzheimer s Research & Therapy
  2. Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
    Li, Chunxiao, Cui, Li, Yang, Yimin, Miao, Jing, Zhao, Xiuzhen, Zhang, Jingdian, Cui, Guohong, Zhang, Ying · 2019 · Frontiers in Molecular Neuroscience
  3. Recent Advances in Biomarkers for Parkinson’s Disease
    Runcheng He, Xinxiang Yan, Jifeng Guo, Qian Xu, Beisha Tang, Qiying Sun · 2018 · Frontiers in Aging Neuroscience
  4. Canadian guideline for Parkinson disease
    Grimes, David, Fitzpatrick, Megan, Gordon, Joyce, Miyasaki, Janis, Fon, Edward A., Schlossmacher, Michael, Suchowersky, Oksana, Rajput, Alexander, Lafontaine, Anne Louise, Mestre, Tiago et al. · 2019 · Canadian Medical Association Journal
  5. The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis
    Simran Rastogi, Vaibhav Sharma, Prahalad Singh Bharti, Komal Rani, Gyan Prakash Modi, Fredrik K. Nikolajeff, Saroj Kumar · 2021 · International Journal of Molecular Sciences
  6. REM S leep B ehavior D isorder in P arkinson's D isease and O ther S ynucleinopathies
    Erik K. St. Louis, Angelica R. Boeve, Bradley F. Boeve · 2017 · Movement Disorders
  7. Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review
    Jeffrey M. Boertien, Pedro A. B. Pereira, Velma T. E. Aho, Filip Scheperjans · 2019 · Journal of Parkinson s Disease
  8. Voice changes in Parkinson’s disease: What are they telling us?
    Andrew Ma, Kenneth K. Lau, Dominic E Thyagarajan · 2020 · Journal of Clinical Neuroscience
  9. The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
    Yuwen Zhao, Lixia Qin, Hongxu Pan, Zhenhua Liu, Jiang Li, Yan He, Qian Zeng, Xun Clare Zhou, Xiaoxia Zhou, Yangjie Zhou et al. · 2020 · Brain
  10. Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts
    Hirotaka Iwaki, Cornelis Blauwendraat, Hampton L. Leonard, Jonggeol Jeffrey Kim, Ganqiang Liu, Jodi Maple‐Grødem, Jean‐Christophe Corvol, Lasse Pihlstrøm, Marlies van Nimwegen, Samantha J. Hutten et al. · 2019 · Movement Disorders
  11. Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
    Isabel Ortuño‐Lizarán, Thomas G. Beach, Geidy E. Serrano, Douglas G. Walker, Charles H. Adler, Nicolás Cuenca · 2018 · Movement Disorders
  12. Movement disorder society criteria for clinically established early Parkinson's disease
    Daniela Berg, Charles H. Adler, Bastiaan R. Bloem, Piu Chan, Thomas Gasser, Christopher G. Goetz, Glenda Margaret Halliday, Anthony Edward Lang, Simon J.G. Lewis, Yuan Li et al. · 2018 · Movement Disorders
  13. Autopsy validation of <sup>123</sup> I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
    Thomas, Alan J., Attems, Johannes, Colloby, Sean J., O'Brien, John T., McKeith, Ian, Walker, Rodney, Lee, Lean, Burn, David, Lett, Debra J., Walker, Zuzana · 2017 · Neurology
  14. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
    Chao Peng, Ronald J. Gathagan, Virginia M.‐Y. Lee · 2017 · Neurobiology of Disease
  15. The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
    David John Irwin, Howard I. Hurtig · 2018 · Journal of Alzheimer’s Disease & Parkinsonism
  16. Tobacco smoking and the risk of Parkinson disease
    Benjamin Mappin‐Kasirer, Hongchao Pan, Sarah Lewington, Jennifer Kizza, Richard G. Gray, Robert Clarke, Richard Peto · 2020 · Neurology
  17. Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease
    Cason B. Robbins, Atalie C. Thompson, Paramjit K. Bhullar, Hui Yan Koo, Rupesh V. Agrawal, Srinath Soundararajan, Stephen P. Yoon, Bryce W. Polascik, Burton L. Scott, Dilraj Singh Grewal et al. · 2020 · JAMA Ophthalmology
  18. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy
    Suman Dutta, Simon Hornung, Adira Kruayatidee, Katherine N. Maina, Irish Del Rosario, Kimberly C. Paul, Darice Y. Wong, Aline Duarte Folle, Daniela Markovic, Jose‐Alberto Palma et al. · 2021 · Acta Neuropathologica
  19. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
    Francesca Garretti, Dritan Agalliu, Cecilia S. Lindestam Arlehamn, Alessandro Sette, David L. Sulzer · 2019 · Frontiers in Immunology
  20. The Neuropsychiatry of Parkinson Disease: A Perfect Storm
    Daniel A. Weintraub, Eugenia Mamikonyan · 2019 · American Journal of Geriatric Psychiatry
  21. Clinical effects of Lewy body pathology in cognitively impaired individuals
    Corinne Quadalti, Sebastian Palmqvist, Sara Hall, Marcello Rossi, Angela Mammana, Shorena Janelidze, Sofia Dellavalle, Niklas Mattsson, Simone Baiardi, Erik Stomrud et al. · 2023 · Nature Medicine
  22. Cognitive effects of Lewy body pathology in clinically unimpaired individuals
    Sebastian Palmqvist, Marcello Rossi, Sara Hall, Corinne Quadalti, Niklas Mattsson, Sofia Dellavalle, Pontus Tideman, Joana B. Pereira, Maria H Nilsson, Angela Mammana et al. · 2023 · Nature Medicine
  23. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
    Giovanni Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, Lorenzo Gaetani, Fabio Moda, Lucilla Parnetti · 2022 · Neurology
  24. Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
    Yumin Wang, Shuang Wu, Qiang Li, Huiyan Sun, Hongquan Wang · 2023 · Advanced Science
  25. Parkinson’s disease biomarkers based on α‐synuclein
    Muneera Fayyad, Safa Salim, Nour K. Majbour, Daniel Erskine, Erik Stoops, Brit Mollenhauer, Omar M. A. El‐Agnaf · 2019 · Journal of Neurochemistry
  26. α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
    Matilde Bongianni, Anna Ladogana, Stefano Capaldi, Sigrid Klotz, Simone Baiardi, Annachiara Cagnin, Daniela Perra, Michele Fiorini, Anna Poleggi, Giuseppe Legname et al. · 2019 · Annals of Clinical and Translational Neurology
  27. Complex networks reveal early MRI markers of Parkinson’s disease
    Nicola Amoroso, Marianna La Rocca, Alfonso Monaco, R. Bellotti, Sabina Tangaro · 2018 · Medical Image Analysis
  28. Serum NFL discriminates Parkinson disease from atypical parkinsonisms
    Marques, Tainá M., van Rumund, Anouke, Oeckl, Patrick, Kuiperij, H. Bea, Esselink, Rianne A.J., Bloem, Bastiaan R., Otto, Markus, Verbeek, Marcel M. · 2019 · Neurology
  29. Clinical and imaging evidence of brain-first and body-first Parkinson's disease
    Jacob Horsager, Karoline Knudsen, Michael Sommerauer · 2022 · Neurobiology of Disease
  30. Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
    Kazuto Tsukita, Haruhi Sakamaki‐Tsukita, Ryōsuke Takahashi · 2022 · Institutional Repositories DataBase (IRDB)
  31. Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management
    Kenji Kondo, Shu Kikuta, Rumi Ueha, Keigo Suzukawa, Tatsuya Yamasoba · 2020 · Frontiers in Aging Neuroscience
  32. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
    Usman Saeed, Anthony Edward Lang, Mario Masellis · 2020 · Frontiers in Neurology
  33. Functional Connectivity Signatures of Parkinson’s Disease
    Alessandro Tessitore, Mario Cirillo, Rosa De Micco · 2019 · Journal of Parkinson s Disease
  34. α‐Synuclein Real‐Time Quaking‐Induced Conversion in the Submandibular Glands of Parkinson's Disease Patients
    Sireesha Manne, Naveen Chandra Kondru, Huajun Jin, Vellareddy Anantharam, Xuemei Huang, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2019 · Movement Disorders
  35. The new definition and diagnostic criteria of Parkinson's disease
    Ronald B. Postuma, Daniela Berg, Charles H. Adler, Bastiaan R. Bloem, Piu Chan, Günther Deuschl, Thomas Gasser, Christopher G. Goetz, Glenda Margaret Halliday, Lawrence Joseph et al. · 2016 · The Lancet Neurology
  36. Probiotics may have beneficial effects in parkinson’s disease: In vitro evidence
    Magistrelli, Luca, Amoruso, Angela, Mogna, Luca, Graziano, Teresa, Cantello, Roberto, Pane, Marco, Comi, Cristoforo · 2019 · Frontiers in Immunology
  37. Neurophysiological correlates of bradykinesia in Parkinson’s disease
    Matteo Bologna, Andrea Guerra, Giulia Paparella, Laura Giordo, Danilo Alunni Fegatelli, Anna Rita Vestri, John C. Rothwell, Alfredo Berardelli · 2018 · Brain
  38. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
    David G. Coughlin, Sharon Xiangwen Xie, Mendy Liang, Andrew Williams, Claire S. Peterson, Daniel A. Weintraub, Corey T. McMillan, David A. Wolk, Rizwan S. Akhtar, Howard I. Hurtig et al. · 2018 · Annals of Neurology
  39. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease
    Sean Hong Tan, Venkatanaidu Karri, Nicole Wuen Rong Tay, Kuan Hui Chang, Hui Yen Ah, Phui Qi Ng, Hui San Ho, Hsiao Wai Keh, Mayuren Candasamy · 2019 · Biomedicine & Pharmacotherapy
  40. An updated review of Parkinson's disease genetics and clinicopathological correlations
    Ferreira, M., Massano, J. · 2017 · Acta Neurologica Scandinavica
  41. The foundation and architecture of precision medicine in neurology and psychiatry
    Harald Juergen Hampel, Peng Gao, Jeffrey L. Cummings, Nicola Toschi, Paul M. Thompson, Yan Hu, Min Cho, Andrea Vergallo · 2023 · Trends in Neurosciences
  42. GaborPDNet: gabor transformation and deep neural network for Parkinson's disease detection using EEG signals
    Loh, Hui Wen, Ooi, Chui Ping, Palmer, Elizabeth, Barua, Prabal Datta, Dogan, Sengul, Tuncer, Turker, Baygin, Mehmet, Acharya, U. Rajendra · 2021 · Electronics
  43. The immune system in Parkinson's disease: what we know so far
    Cintia Roodveldt, Liliana Inácio Bernardino, Özgür Öztop Çakmak, Milorad Dragić, Kari Espolin Fladmark, Sibel Ertan, Büşra Aktaş, Carlos Pita, Lucia Ciglar, Gaëtan Garraux et al. · 2024 · Brain
  44. Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
    Shinji Saiki, Taku Hatano, Motoki Fujimaki, Kei‐ichi Ishikawa, Akio Mori, Yutaka Oji, Ayami Okuzumi, Takeshi Fukuhara, Takahiro Koinuma, Yoko Imamichi et al. · 2017 · Scientific Reports
  45. COVID ‐19 in Parkinson’s Disease Patients Living in Lombardy, Italy
    Alfonso A. Fasano, Emanuele Cereda, Michela Barichella, Erica Cassani, Valentina Ferri, Anna Zecchinelli, Gianni Pezzoli · 2020 · Movement Disorders
  46. Exosomes in Parkinson disease
    Jennifer R. Pinnell, Mei Cui, Kim Tieu · 2020 · Journal of Neurochemistry
  47. Genotype–Phenotype Relations for Isolated Dystonia Genes: MDSGene Systematic Review
    Lara Mariah Lange, Johanna Junker, Sebastian Loens, Hauke Baumann, Luisa Olschewski, Susen Schaake, Harutyun Madoev, Sonja Petkovic, Neele Kuhnke, Meike Kasten et al. · 2021 · Movement Disorders
  48. Selecting Clinically Relevant Gait Characteristics for Classification of Early Parkinson’s Disease: A Comprehensive Machine Learning Approach
    Rana Zia Ur Rehman, Silvia Del Din, Yu Guan, Alison Jane Yarnall, Jian Qing Shi, Lynn Rochester · 2019 · Scientific Reports
  49. Medical Management and Prevention of Motor Complications in Parkinson's Disease
    Stephen D. Aradi, Robert A. Hauser · 2020 · Neurotherapeutics
  50. α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
    Anouke van Rumund, A.J.E Green, Graham Fairfoul, Rianne A.J. Esselink, Bastiaan R. Bloem, Marcel M. Verbeek · 2019 · Annals of Neurology
  51. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder
    Dario Arnaldi, A. Chincarini, Michele T Hu, Karel Šonka, Bradley F. Boeve, Tomoyuki Miyamoto, Monica Puligheddu, Valérie Cochen De Cock, Michele Terzaghi, Giuseppe Plazzi et al. · 2020 · Brain
  52. Prevalence of Parkinson's Disease: A Community‐Based Study in China
    Shige Qi, Peng Yin, Lınhong Wang, Ming Qu, Ge Lin Kan, Han Zhang, Qingjun Zhang, Yize Xiao, Ying Deng, Zhong Dong et al. · 2021 · Movement Disorders
  53. Probiotics synergized with conventional regimen in managing Parkinson’s disease
    Sun, Hairong, Zhao, Feiyan, Liu, Yuanyuan, Ma, Teng, Jin, Hao, Quan, Keyu, Leng, Bing, Zhao, Junwu, Yuan, Xiaoling, Li, Zhenguang et al. · 2022 · npj Parkinson's Disease
  54. Importance of low diagnostic Accuracy for early Parkinson's disease
    Thomas G. Beach, Charles H. Adler · 2018 · Movement Disorders
  55. Microneedle based electrochemical (Bio)Sensing: Towards decentralized and continuous health status monitoring
    Juan José García‐Guzmán, Clara Pérez‐Ràfols, María Cuartero, Gastón A. Crespo · 2020 · TrAC Trends in Analytical Chemistry
  56. Effectiveness of Acupuncture for Anxiety Among Patients With Parkinson Disease
    Jingqi Fan, Wei-Jing Lu, Weiqiang Tan, Xin Liu, Yuting Wang, Nanbu Wang, Lixing Zhuang · 2022 · JAMA Network Open
  57. Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
    Schröder, Jens B., Pawlowski, Matthias, Meyer zu Hörste, Gerd, Gross, Catharina C., Wiendl, Heinz, Meuth, Sven G., Ruck, Tobias, Warnecke, Tobias · 2018 · Frontiers in Neurology
  58. M itochondrial DNA and primary mitochondrial dysfunction in P arkinson's disease
    Maria Pia Giannoccaro, Chiara La Morgia, Giovanni Rizzo, Valério Carelli · 2017 · Movement Disorders
  59. Melatonin for Rapid Eye Movement Sleep Behavior Disorder in Parkinson's disease: A Randomised Controlled Trial
    Moran Gilat, Alessandra Coeytaux Jackson, Nathaniel S. Marshall, Deborah A. Hammond, Anna E. Mullins, Julie M. Hall, Bernard Fang, Brendon John Yee, KEITH K. H. WONG, Ronald R. Grunstein et al. · 2019 · Movement Disorders
  60. Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
    Jannik Prasuhn, Ryan L. Davis, Kishore Raj Kumar · 2021 · Frontiers in Cell and Developmental Biology
  61. Prediction of Freezing of Gait in Parkinson’s Disease Using Wearables and Machine Learning
    Luigi Borzì, Ivan Mazzetta, Alessandro Zampogna, Antonio Suppa, Gabriella Olmo, Fernanda Irrera · 2021 · Sensors
  62. <i>In vivo</i>imaging of neuromelanin in Parkinson’s disease using<sup>18</sup>F-AV-1451 PET
    Hansen, Allan K., Knudsen, Karoline, Lillethorup, Thea P., Landau, Anne M., Parbo, Peter, Fedorova, Tatyana, Audrain, Hélène, Bender, Dirk, Østergaard, Karen, Brooks, David J. et al. · 2016 · Brain
  63. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease
    Jee‐Young Lee, Antonio Martín‐Bastida, Ane Murueta‐Goyena, Iñigo Gabilondo, Nicolás Cuenca, Paola P. Piccini, Beomseok Jeon · 2022 · Nature Reviews Neurology
  64. Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms
    Jesse Mu, К. Ray Chaudhuri, Concha Bielza, Jesús de Pedro-Cuesta, Pedro Larrañaga, Pablo Martínez‐Martín · 2017 · Frontiers in Aging Neuroscience
  65. Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies
    Chiara La Morgia, Lidia Di Vito, Valério Carelli, Michele Carbonelli · 2017 · Frontiers in Neurology
  66. The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study
    К. Ray Chaudhuri, Anette E. Schrag, Daniel A. Weintraub, Alexandra Rizos, Carmen Rodríguez‐Blázquez, Eugenia Mamikonyan, Pablo Martínez‐Martín · 2019 · Movement Disorders
  67. Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes
    Corinne Quadalti, Giovanna Calandra Buonaura, Simone Baiardi, Andrea Mastrangelo, Marcello Rossi, Corrado Zenesini, Giulia Giannini, Niccolò Candelise, Luisa Sambati, Barbara Polischi et al. · 2021 · npj Parkinson s Disease
  68. Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease
    Jan Rusz, Jan Hlavnička, Michal Novotný, Tereza Tykalová, Amélie Pelletier, Jacques Yves Montplaisir, Jean‐François Gagnon, Petr Dušek, Andrea Galbiati, Sara Marelli et al. · 2021 · Annals of Neurology
  69. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort
    Seyed‐Mohammad Fereshtehnejad, Jacques Yves Montplaisir, Amélie Pelletier, Jean‐François Gagnon, Daniela Berg, Ronald B. Postuma · 2017 · Movement Disorders
  70. Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
    Anna‐Elisa Roser, Lucas Caldi Gomes, Jonas Sebastian Schünemann, Fabian Maass, Paul Lingor · 2018 · Frontiers in Neuroscience
  71. Clinical and Imaging Markers of Prodromal Parkinson's Disease
    Eldbjørg Hustad, J. Aasly · 2020 · Frontiers in Neurology
  72. Driving motor cortex oscillations modulates bradykinesia in Parkinson’s disease
    Andrea Guerra, Donato Colella, Margherita Giangrosso, Antonio Cannavacciuolo, Giulia Paparella, Giovanni Fabbrini, Antonio Suppa, Alfredo Berardelli, Matteo Bologna · 2021 · Brain
  73. Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
    Angeliki Zarkali, George E. C. Thomas, Henrik Zetterberg, Rimona Sharon Weil · 2024 · Nature Communications
  74. New Sensor and Wearable Technologies to Aid in the Diagnosis and Treatment Monitoring of Parkinson's Disease
    Mariana H.G. Monje, Guglielmo Foffani, Jose Angel Obeso, Álvaro Sánchez‐Ferro · 2019 · Annual Review of Biomedical Engineering
  75. Fecal microbiota transplant as a potential treatment for Parkinson's disease – A case series
    Segal, Arik, Zlotnik, Yair, Moyal-Atias, Keren, Abuhasira, Ran, Ifergane, Gal · 2021 · Clinical Neurology and Neurosurgery
  76. Potential Roles of Exosomes in Parkinson’s Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis
    Haiyang Yu, Tong Sun, Jing An, Lulu Wen, Fei Liu, Zhongqi Bu, Yueran Cui, Juan Feng · 2020 · Frontiers in Cell and Developmental Biology
  77. Mechanisms of peripheral levodopa resistance in Parkinson’s disease
    Milan Beckers, Bastiaan R. Bloem, Marcel M. Verbeek · 2022 · npj Parkinson s Disease
  78. Parkinson’s disease-like motor and non-motor symptoms in rotenone-treated zebrafish
    Yali Wang, Wenwen Liu, Jing Yang, Fen Wang, Yizhen Sima, Zhaomin Zhong, Han Wang, Li‐Fang Hu, Chun‐Feng Liu · 2016 · NeuroToxicology
  79. Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
    Farzaneh Atashrazm, Deborah A. Hammond, Gayathri Perera, Carol Dobson‐Stone, Nicole Mueller, Russell Pickford, Woojin Scott Kim, John B. Kwok, Simon J.G. Lewis, Glenda Margaret Halliday et al. · 2018 · Scientific Reports
  80. Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease
    Oji, Yutaka, Hatano, Taku, Ueno, Shin-Ichi, Funayama, Manabu, Ishikawa, Kei-ichi, Okuzumi, Ayami, Noda, Sachiko, Sato, Shigeto, Satake, Wataru, Toda, Tatsushi et al. · 2020 · Brain
  81. CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
    William T. Hu, Jennifer Christina Howell, Tugba Tastemel Ozturk, Umesh Gangishetti, Alexander L. Kollhoff, Jaime M. Hatcher-Martin, Albert M. L. Anderson, William R. Tyor · 2019 · Frontiers in Immunology
  82. The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
    Isabel Úbeda‐Bañón, Daniel Saiz‐Sánchez, Alicia Flores‐Cuadrado, E. Rioja Corroto, Melania González-Rodríguez, Sandra Villar‐Conde, Veronica Astillero‐Lopez, Juan Pablo Cabello, Maria José Gallardo‐Alcañiz, Julia Vaamonde‐Gamo et al. · 2020 · Translational Neurodegeneration
  83. A metabolic profile of polyamines in parkinson disease: A promising biomarker
    Shinji Saiki, Yukiko Sasazawa, Motoki Fujimaki, Koji Kamagata, Naoko Kaga, Hikari Taka, Yuanzhe Li, Sanae Souma, Taku Hatano, Yoko Imamichi et al. · 2019 · Annals of Neurology
  84. Cognitive changes in prodromal Parkinson's disease: A review
    Sophie Fengler, Inga Liepelt‐Scarfone, Kathrin Brockmann, Eva Schäffer, Daniela Berg, Elke Kalbe · 2017 · Movement Disorders
  85. Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study
    Anastasia Kuzkina, Connor Bargar, Daniela Schmitt, Jonas Rößle, Wen Wang, Anna-Lena Schubert, Curtis M. Tatsuoka, Steven A. Gunzler, Wen‐Quan Zou, Jens Volkmann et al. · 2021 · npj Parkinson s Disease
  86. Voice in Parkinson's Disease: A Machine Learning Study
    Antonio Suppa, Giovanni Costantini, Francesco Asci, Pietro Leo, Mohammad Sami Al-Wardat, Giulia Di Lazzaro, Simona Scalise, Antonio Pisani, Giovanni Saggio · 2022 · Frontiers in Neurology
  87. Subcortical <sup>18</sup>F‐AV‐1451 binding patterns in progressive supranuclear palsy
    Cho, Hanna, Choi, Jae Yong, Hwang, Mi Song, Lee, Seung Ha, Ryu, Young Hoon, Lee, Myung Sik, Lyoo, Chul Hyoung · 2017 · Movement Disorders
  88. Neurodegeneration and the ordered assembly of α-synuclein
    Maria Grazia Spillantini, Michel Goedert · 2017 · Cell and Tissue Research
  89. α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
    Anna Grossauer, Greta Hemicker, Florian Krismer, Marina Peball, Atbin Djamshidian, Werner H Poewe, Klaus Seppi, Beatrice Heim · 2023 · Movement Disorders Clinical Practice
  90. Technical validation of real-world monitoring of gait: a multicentric observational study
    Claudia Mazzà, Lisa Alcock, Kamiar Aminian, Clemens Becker, Stefano Bertuletti, Tecla Bonci, Philip M. Brown, Marina Brozgol, Ellen E. Buckley, Anne‐Elie Carsin et al. · 2021 · BMJ Open
  91. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I‐FP‐CIT SPECT
    Yun Jung Bae, Jong‐Min Kim, Eunhee Kim, Kyung Mi Lee, Seo Young Kang, Hyun Soo Park, Kyeong Joon Kim, Young Eun Kim, Eungseok Oh, Ji Young Yun et al. · 2016 · Movement Disorders
  92. NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stress
    Alon Simchovitz, Mor Hanan, Naomi Niederhoffer, Nimrod Madrer, Nadav Yayon, Estelle R. Bennett, David Greenberg, Sebastián Kadener, Hermona Soreq · 2019 · The FASEB Journal
  93. Multi-Modal Deep Learning Diagnosis of Parkinson’s Disease—A Systematic Review
    Vasileios Skaramagkas, Anastasia Pentari, Zinovia Maria Kefalopoulou, Manolis Tsiknakis · 2023 · IEEE Transactions on Neural Systems and Rehabilitation Engineering
  94. The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease
    Sanne K. Meles, Remco J. Renken, Annette Janzen, Dávid Vadász, M. Pagani, Dario Arnaldi, Silvia Daniela Morbelli, Flavio Mariano Nobili, Geert Mayer, Klaus Leonhard Leenders et al. · 2018 · Journal of Nuclear Medicine
  95. Smartphone Allows Capture of Speech Abnormalities Associated With High Risk of Developing Parkinson’s Disease
    Jan Rusz, Jan Hlavnička, Tereza Tykalová, Michal Novotný, Petr Dušek, Karel Šonka, Evžen Růžička · 2018 · IEEE Transactions on Neural Systems and Rehabilitation Engineering
  96. Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease
    Muthuraman Muthuraman, Nabin Koirala, Dumitru Ciolac, Bogdan Pintea, Martin B. Glaser, Stanislav A. Groppa, Gertrúd Tamás, Sergiu Groppa · 2018 · Frontiers in Neurology
  97. Frequency of mood and anxiety fluctuations in Parkinson's disease patients with motor fluctuations: A systematic review
    Rachel M J van der Velden, Martijn P. G. Broen, Mark L. Kuijf, Albert F.G. Leentjens · 2018 · Movement Disorders
  98. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
    Xia, Yun, Zhang, Guoxin, Kou, Liang, Yin, Sijia, Han, Chao, Hu, Junjie, Wan, Fang, Sun, Yadi, Wu, Jiawei, Li, Yunna et al. · 2021 · Brain
  99. Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework
    Elie Matar, James M. Shine, Glenda Margaret Halliday, Simon J.G. Lewis · 2019 · Brain
  100. A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs Disease
    Hui Liu, Christos Koros, Timo Strohäker, Claudia Schulte, Maria Bozi, Stefanos Varvaresos, Alain Ibáñez de Opakua, Athina‐Maria Simitsi, Anastasia M. Bougea, Konstantinos I. Voumvourakis et al. · 2021 · Movement Disorders